Skin-Targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ – Mediated Psoriasis-Like Skin Disease In Vivo

• Katrin Hack,

  Affiliation Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, Scotland

  ⨯
• Louise Reilly,

  Affiliation Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, Scotland

  ⨯
• Colin Palmer,

  Affiliation Medical Research Institute, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, Scotland

  ⨯
• Kevin D. Read,

  Affiliation Biological Chemistry and Drug Discovery Unit, College of Life Sciences, University of Dundee, Dundee, Scotland

  ⨯
• Suzanne Norval,

  Affiliation Biological Chemistry and Drug Discovery Unit, College of Life Sciences, University of Dundee, Dundee, Scotland

  ⨯
• Robert Kime,

  Affiliation Biological Chemistry and Drug Discovery Unit, College of Life Sciences, University of Dundee, Dundee, Scotland

  ⨯
• Kally Booth,

  Affiliation Medical School Biological Resource Unit, College of Medicine, Dentistry, and Nursing

  ⨯
• John Foerster

  * E-mail: j.foerster@dundee.ac.uk

  Affiliations Department of Dermatology, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, Scotland, Education Division, College of Medicine, Dentistry, and Nursing, University of Dundee, Dundee, Scotland

  ⨯